Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm - Pfister, D G; Su, Y B; Kraus, D H (J Clin Oncol, 2006)
et al.